Emerging indocyanine green-integrated nanocarriers for multimodal cancer therapy: a review. Issue 12 (10th May 2021)

• Record Type: Journal Article
• Authors: Gowsalya, Karunanidhi; Yasothamani, Vellingiri; Vivek, Raju
• Is Part Of: Nanoscale advances. Volume 3:Issue 12(2021)
• Page Start: 3332
• Page End: 3352
• Publication Date: 2021-05-10
• Subjects: 620.5
• DOI: 10.1039/d1na00059d
• Languages: English
• ISSNs: 2516-0230

Abstract

Abstract : Nanotechnology is a branch of science dealing with the development of new types of nanomaterials by several methods. Abstract : Nanotechnology is a branch of science dealing with the development of new types of nanomaterials by several methods. In the biomedical field, nanotechnology is widely used in the form of nanotherapeutics. Therefore, the current biomedical research pays much attention to nanotechnology for the development of efficient cancer treatment. Indocyanine green (ICG) is a near-infrared tricarbocyanine dye approved by the Food and Drug Administration (FDA) for human clinical use. ICG is a biologically safe photosensitizer and it can kill tumor cells by producing singlet oxygen species and photothermal heat upon NIR irradiation. ICG has some limitations such as easy aggregation, rapid aqueous degradation, and a short half-life. To address these limitations, ICG is further formulated with nanoparticles. Therefore, ICG is integrated with organic nanomaterials (polymers, micelles, liposomes, dendrimers and protein), inorganic nanomaterials (magnetic, gold, mesoporous, calcium, and LDH based), and hybrid nanomaterials. The combination of ICG with nanomaterials provides highly efficient therapeutic effects. Nowadays, ICG is used for various biomedical applications, especially in cancer therapeutics. In this review, we mainly focus on ICG-based combined cancer nanotherapeutics for advanced cancer treatment.